Public Health & Policy
FDA General
More in FDA General
Agency's decision on obeticholic acid in PBC follows negative advisory committee meeting
Nov 12, 2024
ProSense device would be indicated with adjuvant endocrine therapy for some low-risk patients
Nov 08, 2024
Data review shows that oral phenylephrine is not effective as a decongestant, agency says
Nov 07, 2024